Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15


Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents.

Rao PV, Nallappan D, Madhavi K, Rahman S, Jun Wei L, Gan SH.

Oxid Med Cell Longev. 2016;2016:3685671. doi: 10.1155/2016/3685671. Epub 2016 Feb 23. Review.


Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.

Sun C, Yu Y, Wang L, Wu B, Xia L, Feng F, Ling Z, Wang S.

J Exp Clin Cancer Res. 2016 Feb 13;35:32. doi: 10.1186/s13046-015-0274-y.


The Use of Complementary and Alternative Medicine by Korean Breast Cancer Women: Is It Associated with Severity of Symptoms?

Hwang JH, Kim WY, Ahmed M, Choi S, Kim J, Han DW.

Evid Based Complement Alternat Med. 2015;2015:182475. doi: 10.1155/2015/182475. Epub 2015 Dec 3.


Ginseng alleviates cyclophosphamide-induced hepatotoxicity via reversing disordered homeostasis of glutathione and bile acid.

Zhu H, Long MH, Wu J, Wang MM, Li XY, Shen H, Xu JD, Zhou L, Fang ZJ, Luo Y, Li SL.

Sci Rep. 2015 Dec 2;5:17536. doi: 10.1038/srep17536.


Cancer therapy with phytochemicals: evidence from clinical studies.

Hosseini A, Ghorbani A.

Avicenna J Phytomed. 2015 Mar-Apr;5(2):84-97. Review.


Subacute oral toxicity study of korean red ginseng extract in sprague-dawley rats.

Park SJ, Lim KH, Noh JH, Jeong EJ, Kim YS, Han BC, Lee SH, Moon KS.

Toxicol Res. 2013 Dec 31;29(4):285-92. doi: 10.5487/TR.2013.29.4.285.


Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.

Liao GS, Apaya MK, Shyur LF.

Evid Based Complement Alternat Med. 2013;2013:437948. doi: 10.1155/2013/437948. Epub 2013 Jun 12.


Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice.

Yoo DG, Kim MC, Park MK, Song JM, Quan FS, Park KM, Cho YK, Kang SM.

J Med Food. 2012 Oct;15(10):855-62. doi: 10.1089/jmf.2012.0017. Epub 2012 Aug 2.


Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study.

Bao PP, Lu W, Cui Y, Zheng Y, Gu K, Chen Z, Zheng W, Shu XO.

PLoS One. 2012;7(6):e39343. doi: 10.1371/journal.pone.0039343. Epub 2012 Jun 20.


Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action.

Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R.

Front Pharmacol. 2012 Feb 28;3:25. doi: 10.3389/fphar.2012.00025. eCollection 2012.


AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.

Thomssen C, Scharl A, Harbeck N.

Breast Care (Basel). 2011;6(4):299-313. Epub 2011 Aug 30. No abstract available.


Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report.

Ma H, Sullivan-Halley J, Smith AW, Neuhouser ML, Alfano CM, Meeske K, George SM, McTiernan A, McKean-Cowdin R, Baumgartner KB, Ballard-Barbash R, Bernstein L.

BMC Complement Altern Med. 2011 Nov 8;11:109. doi: 10.1186/1472-6882-11-109.


Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

Cui X, Jin Y, Poudyal D, Chumanevich AA, Davis T, Windust A, Hofseth A, Wu W, Habiger J, Pena E, Wood P, Nagarkatti M, Nagarkatti PS, Hofseth L.

Carcinogenesis. 2010 Oct;31(10):1734-41. doi: 10.1093/carcin/bgq163. Epub 2010 Aug 20.


Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.

Liu TG, Huang Y, Cui DD, Huang XB, Mao SH, Ji LL, Song HB, Yi C.

BMC Cancer. 2009 Jul 23;9:250. doi: 10.1186/1471-2407-9-250.


Ginseng on hyperglycemia: effects and mechanisms.

Luo JZ, Luo L.

Evid Based Complement Alternat Med. 2009 Dec;6(4):423-7. doi: 10.1093/ecam/nem178. Epub 2008 Jan 3.

Supplemental Content

Support Center